In vitro screening of metabolic clearance using two concentration points

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Biochemical Assays
• High-Throughput Screening

Background:

• High-throughput screening (HTS) for metabolic stability often uses single-point, single-concentration assays.
• This limited approach fails to provide essential kinetic parameters like K(m) and CL(h).
• Such data is vital for informed decision-making during early drug discovery.

Purpose of the Study:

• To evaluate the utility of using two substrate concentrations in HTS assays.
• To determine if this approach can accurately assess metabolic kinetic values (K(m), V(max), CL(int)).
• To assess the impact of metabolic rate on the reliability of kinetic measurements.

Main Methods:

• Utilized FDA-preferred probe cytochrome P450 substrates.
• Performed assays at two substrate concentrations to determine kinetic parameters.
• Compared experimental K(m) values with FDA-predicted values.

Main Results:

• Compounds with high metabolic rates yielded accurate and reproducible kinetic data.
• Results for high metabolic rate compounds correlated well with FDA-predicted K(m) values.
• Compounds with low metabolic rates produced more variable and less reliable results.

Conclusions:

• Employing two substrate concentrations in screening assays enhances the assessment of metabolic kinetic values.
• This refined methodology provides valuable K(m) and CL(h) data for drug discovery.
• The approach is particularly effective for compounds exhibiting higher metabolic rates.